ClearBridge LLC (Maryland)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | $11.6M | Buy |
119,295
+9,545
| +9% | +$929K | 3.53% | 5 |
|
2018
Q3 | $15.3M | Sell |
109,750
-709,383
| -87% | -$98.6M | 3.74% | 5 |
|
2018
Q2 | $798 | Sell |
819,133
-28,365
| -3% | -$28 | 0.01% | 140 |
|
2018
Q1 | $94.5M | Buy |
847,498
+217,043
| +34% | +$24.2M | 2.1% | 6 |
|
2017
Q4 | $75.4M | Sell |
630,455
-227
| -0% | -$27.1K | 1.57% | 19 |
|
2017
Q3 | $88.5M | Sell |
630,682
-196,158
| -24% | -$27.5M | 1.91% | 11 |
|
2017
Q2 | $101M | Buy |
826,840
+149,780
| +22% | +$18.2M | 2.13% | 10 |
|
2017
Q1 | $82.1M | Sell |
677,060
-12,817
| -2% | -$1.55M | 1.77% | 17 |
|
2016
Q4 | $84.4M | Buy |
689,877
+308
| +0% | +$37.7K | 1.91% | 17 |
|
2016
Q3 | $84.5M | Buy |
689,569
+98,670
| +17% | +$12.1M | 1.61% | 29 |
|
2016
Q2 | $69M | Buy |
590,899
+216,185
| +58% | +$25.2M | 1.37% | 37 |
|
2016
Q1 | $52.2M | Sell |
374,714
-390
| -0.1% | -$54.3K | 1.03% | 42 |
|
2015
Q4 | $71.6M | Sell |
375,104
-11,170
| -3% | -$2.13M | 1.37% | 34 |
|
2015
Q3 | $60.4M | Sell |
386,274
-90,820
| -19% | -$14.2M | 1.23% | 37 |
|
2015
Q2 | $86.2M | Buy |
+477,094
| New | +$86.2M | 1.54% | 32 |
|